Selected research
Industry Research
Prostacyclin (PGI2) ELISA Kits Industry Research Report 2026
Market perspective
The global Prostacyclin (PGI2) ELISA Kits market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prostacyclin (PGI2) ELISA Kits is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prostacyclin (PGI2) ELISA Kits is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prostacyclin (PGI2) ELISA Kits is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prostacyclin (PGI2) ELISA Kits include United States Biological, Fitzgerald Industries International, Enzo Life Sciences, Biomatik Corporation, Aspira Scientific, Abnova, Abcam and Abbexa Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prostacyclin (PGI2) ELISA Kits market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prostacyclin (PGI2) ELISA Kits Market by Company
United States Biological
Fitzgerald Industries International
Enzo Life Sciences
Biomatik Corporation
Aspira Scientific
Abnova
Abcam
Abbexa Ltd
Prostacyclin (PGI2) ELISA Kits Segment by Type
Plasma
Serum
Other Biological Fluid
Prostacyclin (PGI2) ELISA Kits Segment by Application
Laboratories
Hospitals
Prostacyclin (PGI2) ELISA Kits Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin (PGI2) ELISA Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin (PGI2) ELISA Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin (PGI2) ELISA Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prostacyclin (PGI2) ELISA Kits manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prostacyclin (PGI2) ELISA Kits by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prostacyclin (PGI2) ELISA Kits in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plasma
- Serum
- Other Biological Fluid
Applications
- Laboratories
- Hospitals
Companies covered
- United States Biological
- Fitzgerald Industries International
- Enzo Life Sciences
- Biomatik Corporation
- Aspira Scientific
- Abnova
- Abcam
- Abbexa Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prostacyclin (PGI2) ELISA Kits Market Size (2021-2032)
- 2.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales (2021-2032)
- 2.2.3 Global Prostacyclin (PGI2) ELISA Kits Market Average Price (2021-2032)
- 2.3 Prostacyclin (PGI2) ELISA Kits by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Plasma
- 2.3.3 Serum
- 2.3.4 Other Biological Fluid
- 2.4 Prostacyclin (PGI2) ELISA Kits by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Laboratories
- 2.4.3 Hospitals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prostacyclin (PGI2) ELISA Kits Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prostacyclin (PGI2) ELISA Kits Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Prostacyclin (PGI2) ELISA Kits Revenue of Manufacturers (2021-2026)
- 3.4 Global Prostacyclin (PGI2) ELISA Kits Average Price by Manufacturers (2021-2026)
- 3.5 Global Prostacyclin (PGI2) ELISA Kits Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prostacyclin (PGI2) ELISA Kits, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prostacyclin (PGI2) ELISA Kits, Product Type & Application
- 3.8 Global Manufacturers of Prostacyclin (PGI2) ELISA Kits, Established Date
- 3.9 Global Prostacyclin (PGI2) ELISA Kits Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 United States Biological
- 4.1.1 United States Biological Company Information
- 4.1.2 United States Biological Business Overview
- 4.1.3 United States Biological Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 United States Biological Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.1.5 United States Biological Recent Developments
- 4.2 Fitzgerald Industries International
- 4.2.1 Fitzgerald Industries International Company Information
- 4.2.2 Fitzgerald Industries International Business Overview
- 4.2.3 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fitzgerald Industries International Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.2.5 Fitzgerald Industries International Recent Developments
- 4.3 Enzo Life Sciences
- 4.3.1 Enzo Life Sciences Company Information
- 4.3.2 Enzo Life Sciences Business Overview
- 4.3.3 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Enzo Life Sciences Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.3.5 Enzo Life Sciences Recent Developments
- 4.4 Biomatik Corporation
- 4.4.1 Biomatik Corporation Company Information
- 4.4.2 Biomatik Corporation Business Overview
- 4.4.3 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biomatik Corporation Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.4.5 Biomatik Corporation Recent Developments
- 4.5 Aspira Scientific
- 4.5.1 Aspira Scientific Company Information
- 4.5.2 Aspira Scientific Business Overview
- 4.5.3 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Aspira Scientific Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.5.5 Aspira Scientific Recent Developments
- 4.6 Abnova
- 4.6.1 Abnova Company Information
- 4.6.2 Abnova Business Overview
- 4.6.3 Abnova Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Abnova Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.6.5 Abnova Recent Developments
- 4.7 Abcam
- 4.7.1 Abcam Company Information
- 4.7.2 Abcam Business Overview
- 4.7.3 Abcam Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Abcam Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.7.5 Abcam Recent Developments
- 4.8 Abbexa Ltd
- 4.8.1 Abbexa Ltd Company Information
- 4.8.2 Abbexa Ltd Business Overview
- 4.8.3 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Abbexa Ltd Prostacyclin (PGI2) ELISA Kits Product Portfolio
- 4.8.5 Abbexa Ltd Recent Developments
5 Global Prostacyclin (PGI2) ELISA Kits Market Scenario by Region
- 5.1 Global Prostacyclin (PGI2) ELISA Kits Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021-2032
- 5.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2021-2026
- 5.2.2 Global Prostacyclin (PGI2) ELISA Kits Sales by Region: 2027-2032
- 5.3 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region: 2021-2032
- 5.3.1 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region: 2021-2026
- 5.3.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Region: 2027-2032
- 5.4 North America Prostacyclin (PGI2) ELISA Kits Market Facts & Figures by Country
- 5.4.1 North America Prostacyclin (PGI2) ELISA Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
- 5.4.3 North America Prostacyclin (PGI2) ELISA Kits Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prostacyclin (PGI2) ELISA Kits Market Facts & Figures by Country
- 5.5.1 Europe Prostacyclin (PGI2) ELISA Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
- 5.5.3 Europe Prostacyclin (PGI2) ELISA Kits Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prostacyclin (PGI2) ELISA Kits Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prostacyclin (PGI2) ELISA Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prostacyclin (PGI2) ELISA Kits Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prostacyclin (PGI2) ELISA Kits Market Facts & Figures by Country
- 5.7.1 South America Prostacyclin (PGI2) ELISA Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
- 5.7.3 South America Prostacyclin (PGI2) ELISA Kits Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Prostacyclin (PGI2) ELISA Kits Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prostacyclin (PGI2) ELISA Kits Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prostacyclin (PGI2) ELISA Kits Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prostacyclin (PGI2) ELISA Kits Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021-2032)
- 6.1.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Type (2021-2032)
- 6.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Type (2021-2032)
- 6.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Type (2021-2032)
- 6.3 Global Prostacyclin (PGI2) ELISA Kits Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021-2032)
- 7.1.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Prostacyclin (PGI2) ELISA Kits Sales Market Share by Application (2021-2032)
- 7.2 Global Prostacyclin (PGI2) ELISA Kits Revenue by Application (2021-2032)
- 7.2.1 Global Prostacyclin (PGI2) ELISA Kits Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prostacyclin (PGI2) ELISA Kits Revenue Market Share by Application (2021-2032)
- 7.3 Global Prostacyclin (PGI2) ELISA Kits Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prostacyclin (PGI2) ELISA Kits Value Chain Analysis
- 8.1.1 Prostacyclin (PGI2) ELISA Kits Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prostacyclin (PGI2) ELISA Kits Production Mode & Process
- 8.2 Prostacyclin (PGI2) ELISA Kits Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prostacyclin (PGI2) ELISA Kits Distributors
- 8.2.3 Prostacyclin (PGI2) ELISA Kits Customers
9 Global Prostacyclin (PGI2) ELISA Kits Analyzing Market Dynamics
- 9.1 Prostacyclin (PGI2) ELISA Kits Industry Trends
- 9.2 Prostacyclin (PGI2) ELISA Kits Industry Drivers
- 9.3 Prostacyclin (PGI2) ELISA Kits Industry Opportunities and Challenges
- 9.4 Prostacyclin (PGI2) ELISA Kits Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst